EyePoint Pharmaceuticals Inc. logo

EyePoint Pharmaceuticals Inc. (EYPT)

Market Open
1 Sep, 19:42
NASDAQ (NMS) NASDAQ (NMS)
$
4. 54
+0.04
+1%
$
377.29M Market Cap
- P/E Ratio
- Div Yield
2.32M Volume
-1.94 Eps
$ 4.5
Previous Close
Analysts:
Add Transaction
Day Range
4.35 4.61
Year Range
3.95 19.11
Want to track EYPT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

EyePoint Pharmaceuticals Inc. (EYPT) Statistics

Valuation metrics

Market Cap 377.29M
Enterprise value 287.52M
Trailing P/E (ttm) -1.2
Forward P/E -
PEG ratio 0.04
Price/Sales (ttm) 134.68
Price/Book (mrq) 2.33
Enterprise Value/Revenue 103.09
Enterprise Value/EBITDA -0.98

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 4.39M
Average volume (90 days) 1.85M

Price summary

52-Week low 3.95
52-Week high 19.11
Beta -
50-Day moving average 11.63
200-Day moving average 13.87

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 9 Dec 2020

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -109.95%
Operating margin -113.65%

Operational effectiveness

Return on assets -1.34%
Return on equity -1.36%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 0.03
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.54
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 2.09
Total debt (mrq) -
Total Debt/Equity (mrq) 0.13
Current ratio (mrq) 4.5%
Book value per share (mrq) 1.92

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -